Pharma News

Telomir Pharmaceuticals announced results from its recent preclinical studies conducted in human retinal cell lines.  These studies demonstrated the ability of Telomir-1 to significantly rev...

Innate’s lacutamab gains FDA breakthrough therapy designation

FDA grants Fast Track Status to Rznomics’ RZ-001 for the treatment of hepatocellular carcinoma

Drug Discovery Preclinical CRO Market Growth Accelerating at 6.17% CAGR to 30.5 Billion USD by 2032

GSK’s Penmenvy meningococcal vaccine gains FDA approval

A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes

Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US

Galderma enters fierce European atopic dermatitis market with Nemluvio approval

Cell therapy weekly: preclinical programs for tumor-activated immunotherapies

FDA Approves Merilog as Biosimilar to Insulin Aspart for Diabetes

Robert F. Kennedy Jr Confirmed as HHS Secretary, Nearly Along Party Lines

US Government actions having a serious impact on global health, WHO chief says